0000000000519482

AUTHOR

Joan Tosca-cuquerella

0000-0003-1258-9513

showing 2 related works from this author

Could HLA-DQ suggest why some patients have olmesartan-related diarrhea and others don't?

2015

Malemedicine.medical_specialtyHepatologybusiness.industryDuodenumGastroenterologyGastroenterologyDiarrheaCeliac Diseasemedicine.anatomical_structureIntestinal mucosaInternal medicineHLA-DQmedicineDuodenumHumansFemalemedicine.symptomIntestinal MucosabusinessOlmesartanImmunosuppressive Agentsmedicine.drugThe American journal of gastroenterology
researchProduct

Amyloidosis in Inflammatory Bowel Disease: A Systematic Review of Epidemiology, Clinical Features, and Treatment.

2015

Background and Aims: Amyloidosis is a rare complication of inflammatory bowel disease [IBD]; its low prevalence has hindered both descriptive and therapeutic studies. The aim of this study was to estimate the prevalence of amyloidosis in IBD and the risk factors associated with this complication. Methods: This paper presents an observational study, followed by a systematic review of the epidemiological and clinical characteristics of the disease and a review of the diagnostic and therapeutic options. Results: The prevalence of amyloidosis among IBD patients is 0.53% (95% confidence interval [CI]: 0.32–0.75), although epidemiological data suggest that it may be under-diagnosed. The phenotype…

medicine.medical_specialtymedicine.medical_treatmentDiseaseInflammatory bowel disease03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicineEpidemiologymedicinePrevalenceHumansProteinuriabusiness.industryAmyloidosisGastroenterologyImmunosuppressionGeneral MedicineAmyloidosismedicine.diseaseInflammatory Bowel DiseasesSurgeryPhenotypeTreatment Outcome030220 oncology & carcinogenesis030211 gastroenterology & hepatologyObservational studymedicine.symptomComplicationbusinessJournal of Crohn'scolitis
researchProduct